NDC product
Meclizine HCl
NDC 16571-824 · Rising Pharma Holdings, Inc.
Key facts
| Product NDC | 16571-824 |
|---|---|
| Proprietary name | Meclizine HCl |
| Nonproprietary name | MECLIZINE HYDROCHLORIDE CHEWABLE |
| Substances | MECLIZINE HYDROCHLORIDE |
| Dosage form | TABLET, CHEWABLE |
| Route | ORAL |
| Labeler | Rising Pharma Holdings, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M009.50 |
| Pharmacologic classes | Antiemetic [EPC], Emesis Suppression [PE] |
| Marketing start | Aug 18, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: